An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo.
Saved in:
| Title: | An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo. |
|---|---|
| Authors: | Adams JJ; Anvil Institute for Systems Biologics, Canada.; Simisco Biosciences, USA., Blazer LL; Anvil Institute for Systems Biologics, Canada., Chung J; Anvil Institute for Systems Biologics, Canada.; EPOK Therapeutics, Canada., Karimi M; Université de Montréal, Canada., Davidson T; University of Texas Southwestern Medical Center, USA., Bruce HA; Anvil Institute for Systems Biologics, Canada., Singer AU; Anvil Institute for Systems Biologics, Canada., Yang N; Anvil Institute for Systems Biologics, Canada., Cardarelli L; Anvil Institute for Systems Biologics, Canada., Pot I; Anvil Institute for Systems Biologics, Canada., Colombo L; EPOK Therapeutics, Canada., Huang LJ; University of Texas Southwestern Medical Center, USA., Ma Y; University of Texas Southwestern Medical Center, USA., Michnick SW; Université de Montréal, Canada., Moe OW; EPOK Therapeutics, Canada.; University of Texas Southwestern Medical Center, USA., Sidhu SS; Anvil Institute for Systems Biologics, Canada.; Simisco Biosciences, USA.; EPOK Therapeutics, Canada. |
| Source: | Protein science : a publication of the Protein Society [Protein Sci] 2025 Oct; Vol. 34 (10), pp. e70292. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet ISSN: 1469-896X (Electronic) Linking ISSN: 09618368 NLM ISO Abbreviation: Protein Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
